Royal Bank of Canada’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
25
-962
| -97% | – | ﹤0.01% | 6765 |
|
|
2025
Q1 | $11K | Sell |
987
-190
| -16% | -$2.12K | ﹤0.01% | 5741 |
|
|
2024
Q4 | $15K | Buy |
1,177
+342
| +41% | +$4.36K | ﹤0.01% | 5737 |
|
|
2024
Q3 | $23K | Buy |
835
+79
| +10% | +$2.18K | ﹤0.01% | 5586 |
|
|
2024
Q2 | $22K | Buy |
756
+555
| +276% | +$16.2K | ﹤0.01% | 5644 |
|
|
2024
Q1 | $9K | Sell |
201
-2,354
| -92% | -$105K | ﹤0.01% | 5792 |
|
|
2023
Q4 | $99K | Buy |
2,555
+1,096
| +75% | +$42.5K | ﹤0.01% | 5100 |
|
|
2023
Q3 | $43K | Buy |
1,459
+554
| +61% | +$16.3K | ﹤0.01% | 5372 |
|
|
2023
Q2 | $58K | Buy |
905
+421
| +87% | +$27K | ﹤0.01% | 5254 |
|
|
2023
Q1 | $23K | Sell |
484
-592
| -55% | -$28.1K | ﹤0.01% | 5585 |
|
|
2022
Q4 | $74K | Buy |
1,076
+971
| +925% | +$66.8K | ﹤0.01% | 5192 |
|
|
2022
Q3 | $15K | Buy |
105
+56
| +114% | +$8K | ﹤0.01% | 5767 |
|
|
2022
Q2 | $6K | Sell |
49
-407
| -89% | -$49.8K | ﹤0.01% | 6117 |
|
|
2022
Q1 | $46K | Buy |
456
+197
| +76% | +$19.9K | ﹤0.01% | 5670 |
|
|
2021
Q4 | $40K | Buy |
259
+118
| +84% | +$18.2K | ﹤0.01% | 5966 |
|
|
2021
Q3 | $41K | Buy |
+141
| New | +$41K | ﹤0.01% | 5756 |
|